OLOPATADINE HYDROCHLORIDE

OLOPATADINE HYDROCHLORIDE was reported 5840 times

OLOPATADINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 WRONG PRODUCT PROCURED 6 0.0909
1 CORYNEBACTERIUM SEPSIS 3 0.0455
2 TREATMENT FAILURE 1943 0.0234
3 DISORDER OF ORBIT 3 0.0208
4 BRACHYCEPHALY 2 0.0198
5 EYELID BLEEDING 3 0.0173
6 EYE DISCHARGE 178 0.0171
7 EXPOSURE TO ALLERGEN 5 0.0157
8 STICKY SKIN 6 0.0150
9 PRODUCT ADVERTISING ISSUE 3 0.0140
10 PIERRE ROBIN SYNDROME 3 0.0140
11 EYELID INFECTION 6 0.0136
12 URTICARIAL VASCULITIS 7 0.0133
13 HUMIDITY INTOLERANCE 5 0.0125
14 AORTIC VALVE THICKENING 2 0.0124
15 PARANASAL CYST 3 0.0123
16 HYPOAESTHESIA EYE 7 0.0119
17 EYELID MARGIN CRUSTING 34 0.0118
18 PRODUCT WITH QUALITY ISSUE ADMINISTERED 5 0.0112
19 KERATOCONUS 4 0.0106
20 THROMBOTIC CEREBRAL INFARCTION 4 0.0106
21 THYROIDITIS SUBACUTE 3 0.0103
22 PATIENT DISSATISFACTION WITH TREATMENT 19 0.0098
23 PRODUCT DELIVERY MECHANISM ISSUE 53 0.0098
24 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
25 LICHENIFICATION 4 0.0097
26 CONJUNCTIVITIS ALLERGIC 14 0.0094
27 CENTRAL VISION LOSS 2 0.0090
28 ECZEMA HERPETICUM 4 0.0086
29 LIP EROSION 6 0.0082
30 SCLERODERMA RENAL CRISIS 3 0.0079
31 VEIN COLLAPSE 6 0.0078
32 CARDIOVASCULAR SYMPTOM 3 0.0077
33 PRODUCT AFTER TASTE 7 0.0073
34 ANTITHROMBIN III DECREASED 2 0.0073
35 CHEMICAL BURNS OF EYE 2 0.0072
36 MYOFASCIAL PAIN SYNDROME 5 0.0070
37 PRODUCT CLOSURE REMOVAL DIFFICULT 7 0.0069
38 PRODUCT PHYSICAL CONSISTENCY ISSUE 38 0.0069
39 ALOPECIA UNIVERSALIS 2 0.0068
40 OCULAR DISCOMFORT 76 0.0068
41 ASPERGILLUS TEST POSITIVE 2 0.0065
42 BLOOD PRESSURE SYSTOLIC ABNORMAL 16 0.0065
43 MANUFACTURING ISSUE 3 0.0065
44 EYE ALLERGY 10 0.0065
45 EYELID EXFOLIATION 5 0.0063
46 ALLERGY TO ARTHROPOD BITE 2 0.0063
47 ADMINISTRATION SITE SWELLING 2 0.0062
48 EYELID RASH 6 0.0061
49 UPPER RESPIRATORY TRACT INFLAMMATION 7 0.0058
50 FACIAL DISCOMFORT 4 0.0056
51 PRODUCT OUTER PACKAGING ISSUE 5 0.0055
52 EYE IRRITATION 314 0.0054
53 CYTOMEGALOVIRUS ENTEROCOLITIS 4 0.0052
54 EYELID IRRITATION 13 0.0052
55 ABNORMAL SENSATION IN EYE 21 0.0049
56 LIQUID PRODUCT PHYSICAL ISSUE 35 0.0048
57 SINUSITIS BACTERIAL 5 0.0047
58 PERIORBITAL PAIN 4 0.0047
59 FOREIGN BODY SENSATION IN EYES 30 0.0047
60 EYE PRURITUS 156 0.0046
61 SWELLING OF EYELID 29 0.0046
62 INFUSION SITE DISCHARGE 8 0.0046
63 HEAT ILLNESS 3 0.0044
64 RENAL COLIC 10 0.0044
65 BIOPSY BONE MARROW 2 0.0043
66 PNEUMONIA INFLUENZAL 5 0.0042
67 PRODUCT DESIGN ISSUE 3 0.0042
68 INFUSION SITE BRUISING 9 0.0042
69 INFUSION SITE PRURITUS 13 0.0041
70 ERYTHEMA OF EYELID 22 0.0041
71 MITRAL VALVE DISEASE 7 0.0040
72 EYELID PAIN 8 0.0039
73 AORTIC VALVE CALCIFICATION 2 0.0039
74 SUPERFICIAL INJURY OF EYE 4 0.0037
75 TONGUE ERYTHEMA 3 0.0036
76 DEVICE INFUSION ISSUE 9 0.0036
77 EYELIDS PRURITUS 11 0.0035
78 CRANIOSYNOSTOSIS 3 0.0035
79 THALAMUS HAEMORRHAGE 3 0.0034
80 PRODUCT CONTAINER SEAL ISSUE 6 0.0034
81 EYE PAIN 189 0.0033
82 OCULAR HYPERAEMIA 157 0.0033
83 PUNCTATE KERATITIS 3 0.0033
84 CERVICOBRACHIAL SYNDROME 2 0.0033
85 ORAL MUCOSA EROSION 4 0.0033
86 TONGUE INJURY 3 0.0032
87 PRODUCT PACKAGE ASSOCIATED INJURY 7 0.0031
88 PRODUCT PACKAGING DIFFICULT TO OPEN 8 0.0031
89 LIP INJURY 4 0.0031
90 INFUSION SITE HAEMORRHAGE 10 0.0030
91 SUSPECTED PRODUCT CONTAMINATION 3 0.0030
92 TYMPANIC MEMBRANE PERFORATION 5 0.0030
93 ENTERITIS INFECTIOUS 5 0.0029
94 FULMINANT TYPE 1 DIABETES MELLITUS 3 0.0029
95 BONE MARROW OEDEMA 3 0.0029
96 INFUSION SITE DISCOMFORT 3 0.0029
97 RESPIRATORY TRACT IRRITATION 3 0.0029
98 ALOPECIA AREATA 5 0.0028
99 CHYLOTHORAX 2 0.0028
100 PRODUCT SELECTION ERROR 3 0.0027
101 HYPERURICAEMIA 11 0.0027
102 PERIORBITAL SWELLING 15 0.0027
103 CHOLANGITIS ACUTE 2 0.0026
104 RUBBER SENSITIVITY 4 0.0026
105 ADMINISTRATION SITE PAIN 3 0.0026
106 ERYTHEMA MULTIFORME 24 0.0026
107 IMMUNE-MEDIATED HEPATIC DISORDER 5 0.0026
108 PYELONEPHRITIS ACUTE 5 0.0025
109 BRONCHIAL HYPERREACTIVITY 3 0.0025
110 OTITIS EXTERNA 3 0.0025
111 INFUSION SITE ERYTHEMA 20 0.0024
112 LACRIMATION INCREASED 71 0.0023
113 INFUSION SITE IRRITATION 3 0.0023
114 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
115 PEMPHIGOID 17 0.0023
116 RHINITIS ALLERGIC 10 0.0022
117 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
118 INFUSION SITE SWELLING 14 0.0022
119 PRODUCT CONTAINER ISSUE 19 0.0022
120 SEASONAL ALLERGY 31 0.0022
121 CERUMEN IMPACTION 2 0.0022
122 EYELID DISORDER 5 0.0022
123 RESPIRATORY TRACT INFECTION VIRAL 5 0.0021
124 EYE SWELLING 78 0.0021
125 POST HERPETIC NEURALGIA 3 0.0021
126 MULTIPLE ALLERGIES 16 0.0020
127 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
128 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
129 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
130 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
131 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
132 CHOLANGITIS 12 0.0019
133 ALLERGY TO ANIMAL 2 0.0019
134 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 2 0.0019
135 SKIN EROSION 6 0.0019
136 IMMUNE-MEDIATED MYOCARDITIS 3 0.0019
137 VITREOUS DETACHMENT 4 0.0018
138 CONJUNCTIVITIS 34 0.0018
139 ARTHROPOD STING 3 0.0018
140 RESPIRATORY SYMPTOM 5 0.0018
141 DRUG ERUPTION 31 0.0017
142 PRODUCT ODOUR ABNORMAL 18 0.0017
143 VISION BLURRED 232 0.0017
144 DRUG EFFECT LESS THAN EXPECTED 25 0.0017
145 DRY EYE 84 0.0017
146 SKIN WEEPING 6 0.0017
147 INFUSION SITE REACTION 5 0.0017
148 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
149 INFUSION SITE PAIN 21 0.0016
150 WRONG PRODUCT ADMINISTERED 11 0.0016
151 CHRONIC SINUSITIS 6 0.0016
152 WHITE BLOOD CELLS URINE POSITIVE 3 0.0016
153 EYE INFECTION 18 0.0016
154 PARONYCHIA 7 0.0016
155 SACROILIITIS 3 0.0016
156 LIGAMENT RUPTURE 7 0.0016
157 CLEFT PALATE 3 0.0016
158 CONCOMITANT DISEASE PROGRESSION 3 0.0015
159 BLEPHARITIS 6 0.0015
160 PRODUCT SIZE ISSUE 8 0.0015
161 SUDDEN HEARING LOSS 3 0.0015
162 LUNG ABSCESS 3 0.0014
163 BREATH SOUNDS ABNORMAL 7 0.0014
164 EAR SWELLING 3 0.0014
165 TORTICOLLIS 3 0.0014
166 FIBULA FRACTURE 4 0.0014
167 HYPERTONIC BLADDER 4 0.0014
168 PRODUCT COLOUR ISSUE 7 0.0014
169 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
170 PRODUCT LOT NUMBER ISSUE 3 0.0014
171 APRAXIA 2 0.0013
172 METABOLIC ENCEPHALOPATHY 4 0.0013
173 THYROIDITIS 4 0.0013
174 NEPHROGENIC SYSTEMIC FIBROSIS 4 0.0013
175 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
176 EAR DISORDER 6 0.0013
177 FOOD POISONING 7 0.0013
178 ORAL PRURITUS 3 0.0013
179 BLOOD PRESSURE IMMEASURABLE 2 0.0013
180 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
181 MENOPAUSAL SYMPTOMS 3 0.0013
182 HEPATIC FUNCTION ABNORMAL 48 0.0013
183 DYSMORPHISM 3 0.0013
184 SINUS OPERATION 3 0.0013
185 ADRENAL INSUFFICIENCY 15 0.0012
186 PHOTOPHOBIA 23 0.0012
187 POLYP 8 0.0012
188 EOSINOPHIL COUNT INCREASED 10 0.0012
189 CEREBELLAR INFARCTION 2 0.0012
190 BLOOD PH DECREASED 2 0.0012
191 DISSEMINATED TUBERCULOSIS 3 0.0012
192 PHYSICAL DECONDITIONING 3 0.0012
193 ACUTE SINUSITIS 2 0.0012
194 PRODUCT PACKAGING ISSUE 11 0.0012
195 HORDEOLUM 5 0.0012
196 DERMATITIS ACNEIFORM 7 0.0011
197 EMBOLIC STROKE 4 0.0011
198 GLOSSITIS 4 0.0011
199 AORTIC VALVE STENOSIS 2 0.0011
200 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
201 VASCULAR DEVICE INFECTION 5 0.0011
202 HAEMOGLOBIN INCREASED 5 0.0011
203 SPINAL COMPRESSION FRACTURE 9 0.0011
204 AMYLASE INCREASED 4 0.0011
205 NEPHROGENIC ANAEMIA 5 0.0011
206 PRODUCT USE COMPLAINT 17 0.0011
207 PRODUCT LEAKAGE 6 0.0011
208 IMPULSIVE BEHAVIOUR 4 0.0011
209 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
210 BLOOD PRESSURE FLUCTUATION 25 0.0010
211 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
212 PRODUCT LABEL ISSUE 7 0.0010
213 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
214 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
215 BODY TEMPERATURE DECREASED 10 0.0010
216 LIGAMENT SPRAIN 10 0.0010
217 ATYPICAL PNEUMONIA 3 0.0010
218 AZOTAEMIA 4 0.0010
219 OBSTRUCTION 4 0.0010
220 INTERNATIONAL NORMALISED RATIO DECREASED 4 0.0010
221 RECTAL CANCER 3 0.0010
222 INCREASED UPPER AIRWAY SECRETION 5 0.0010
223 CHOLANGITIS SCLEROSING 2 0.0010
224 PHARYNGITIS 12 0.0010
225 POOR VENOUS ACCESS 10 0.0010
226 SINUSITIS 98 0.0010
227 INTERSTITIAL LUNG DISEASE 46 0.0009
228 PHOTOPSIA 6 0.0009
229 EAR INFECTION 25 0.0009
230 PRODUCT DISPENSING ISSUE 4 0.0009
231 HYPOGAMMAGLOBULINAEMIA 6 0.0009
232 NEUTROPHIL COUNT DECREASED 37 0.0009
233 CATHETERISATION CARDIAC 4 0.0009
234 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
235 BRONCHIECTASIS 6 0.0009
236 OROPHARYNGEAL DISCOMFORT 8 0.0009
237 BLOOD LOSS ANAEMIA 2 0.0009
238 BRAIN OPERATION 2 0.0009
239 HERPES VIRUS INFECTION 5 0.0009
240 PRODUCTIVE COUGH 41 0.0009
241 EAR PRURITUS 3 0.0009
242 TIBIA FRACTURE 4 0.0009
243 SINUS HEADACHE 5 0.0008
244 EYE INFLAMMATION 8 0.0008
245 PHARYNGITIS STREPTOCOCCAL 9 0.0008
246 MONOCYTE COUNT INCREASED 3 0.0008
247 BLOOD PHOSPHORUS DECREASED 3 0.0008
248 BLOOD PRESSURE SYSTOLIC INCREASED 16 0.0008
249 PSEUDOMONAS INFECTION 7 0.0008
250 VIRAL INFECTION 27 0.0008
251 BRONCHITIS 60 0.0008
252 PULMONARY MASS 12 0.0008
253 PNEUMONIA ASPIRATION 20 0.0008
254 HYPERAMMONAEMIA 4 0.0008
255 CORONARY ARTERY STENOSIS 4 0.0008
256 GASTROINTESTINAL INFECTION 7 0.0008
257 SKIN ULCER 20 0.0008
258 APHTHOUS ULCER 6 0.0008
259 ORAL INFECTION 3 0.0008
260 SKIN FISSURES 15 0.0008
261 ACCIDENTAL OVERDOSE 28 0.0008
262 PNEUMONIA BACTERIAL 7 0.0008
263 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
264 ORAL CANDIDIASIS 10 0.0008
265 DIVERTICULITIS 21 0.0008
266 SINUS DISORDER 15 0.0008
267 NASAL DISCOMFORT 6 0.0008
268 PRODUCT DISTRIBUTION ISSUE 7 0.0008
269 OESOPHAGEAL CANDIDIASIS 3 0.0008
270 EXPIRED PRODUCT ADMINISTERED 25 0.0008
271 ANIMAL BITE 2 0.0007
272 CHOLECYSTITIS CHRONIC 5 0.0007
273 COMPRESSION FRACTURE 4 0.0007
274 BREAST MASS 5 0.0007
275 FUNGAL SKIN INFECTION 3 0.0007
276 PRODUCT RESIDUE PRESENT 4 0.0007
277 NEURALGIA 18 0.0007
278 POST PROCEDURAL INFECTION 6 0.0007
279 INJECTION SITE EXTRAVASATION 9 0.0007
280 ANAPHYLACTOID REACTION 3 0.0007
281 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
282 SECRETION DISCHARGE 9 0.0007
283 AUTOIMMUNE DISORDER 7 0.0007
284 MACULAR OEDEMA 4 0.0007
285 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
286 SENSATION OF FOREIGN BODY 6 0.0007
287 RHINORRHOEA 46 0.0007
288 ATYPICAL FEMUR FRACTURE 2 0.0007
289 THERMAL BURN 5 0.0007
290 GENERALISED ERYTHEMA 4 0.0007
291 DERMATITIS CONTACT 8 0.0007
292 SCAB 8 0.0007
293 EXERCISE TOLERANCE DECREASED 4 0.0007
294 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
295 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
296 MYELODYSPLASTIC SYNDROME 10 0.0007
297 SKIN SWELLING 6 0.0007
298 CHAPPED LIPS 3 0.0007
299 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
300 FUNGAL INFECTION 23 0.0007
301 RALES 4 0.0007
302 PRODUCT LABEL CONFUSION 4 0.0007
303 GASTROENTERITIS 10 0.0007
304 HYPERTRIGLYCERIDAEMIA 4 0.0007
305 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
306 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
307 STEVENS-JOHNSON SYNDROME 15 0.0007
308 EYE HAEMORRHAGE 9 0.0007
309 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
310 PROTHROMBIN TIME PROLONGED 4 0.0007
311 EAR PAIN 13 0.0007
312 IRON DEFICIENCY 3 0.0007
313 SINUS CONGESTION 9 0.0007
314 TYPE 1 DIABETES MELLITUS 4 0.0007
315 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
316 CEREBRAL INFARCTION 16 0.0007
317 CANDIDA INFECTION 11 0.0007
318 ROSACEA 3 0.0006
319 BACTERIAL INFECTION 12 0.0006
320 EYE DISORDER 21 0.0006
321 BLOOD CREATININE DECREASED 2 0.0006
322 ASTHMA 72 0.0006
323 BLEPHAROSPASM 4 0.0006
324 RHINITIS 5 0.0006
325 BACTERIAL SEPSIS 2 0.0006
326 INCORRECT DOSAGE ADMINISTERED 3 0.0006
327 NASAL POLYPS 3 0.0006
328 STAPHYLOCOCCAL SEPSIS 3 0.0006
329 TOOTH INFECTION 8 0.0006
330 ORGANISING PNEUMONIA 3 0.0006
331 HYPERSENSITIVITY 112 0.0006
332 MADAROSIS 7 0.0006
333 FLUID INTAKE REDUCED 3 0.0006
334 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
335 TOXIC SKIN ERUPTION 6 0.0006
336 NASAL CONGESTION 35 0.0006
337 TOXIC ENCEPHALOPATHY 3 0.0006
338 MIDDLE INSOMNIA 11 0.0006
339 PHLEBITIS 3 0.0006
340 RENAL IMPAIRMENT 49 0.0006
341 MUSCLE STRAIN 5 0.0006
342 PYELONEPHRITIS 5 0.0006
343 TENDERNESS 6 0.0006
344 BRONCHIOLITIS 2 0.0006
345 PNEUMOTHORAX 9 0.0006
346 PULMONARY TOXICITY 4 0.0006
347 ORAL HERPES 11 0.0006
348 BODY HEIGHT DECREASED 6 0.0006
349 HEREDITARY ANGIOEDEMA 6 0.0006
350 GINGIVITIS 3 0.0006
351 CELLULITIS 28 0.0006
352 ECZEMA 29 0.0006
353 LIMB INJURY 15 0.0006
354 ASTHENOPIA 3 0.0005
355 SKIN HAEMORRHAGE 8 0.0005
356 HEPATIC STEATOSIS 10 0.0005
357 BLOOD CHOLESTEROL INCREASED 25 0.0005
358 DYSPNOEA EXERTIONAL 20 0.0005
359 PULMONARY CONGESTION 7 0.0005
360 REBOUND EFFECT 6 0.0005
361 MITRAL VALVE INCOMPETENCE 6 0.0005
362 CHOLECYSTITIS ACUTE 3 0.0005
363 ADVERSE REACTION 7 0.0005
364 FEBRILE NEUTROPENIA 35 0.0005
365 INTERNAL HAEMORRHAGE 6 0.0005
366 INSURANCE ISSUE 8 0.0005
367 C-REACTIVE PROTEIN INCREASED 19 0.0005
368 DEVICE RELATED INFECTION 8 0.0005
369 EYELID OEDEMA 6 0.0005
370 UVEITIS 7 0.0005
371 SKIN WARM 3 0.0005
372 ACUTE MYELOID LEUKAEMIA 8 0.0005
373 BLOOD PRESSURE DECREASED 34 0.0005
374 COVID-19 PNEUMONIA 6 0.0005
375 BLOOD ALBUMIN DECREASED 4 0.0005
376 MELAENA 11 0.0005
377 CYTOKINE RELEASE SYNDROME 10 0.0005
378 RESTLESS LEGS SYNDROME 9 0.0005
379 PRODUCT ADMINISTRATION ERROR 10 0.0005
380 TASTE DISORDER 10 0.0005
381 ASPHYXIA 4 0.0005
382 INITIAL INSOMNIA 5 0.0005
383 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
384 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
385 ILLNESS 50 0.0005
386 AORTIC DISSECTION 2 0.0005
387 INFUSION RELATED REACTION 32 0.0005
388 INFUSION SITE EXTRAVASATION 3 0.0005
389 NASAL DRYNESS 3 0.0005
390 DRUG-INDUCED LIVER INJURY 15 0.0005
391 BLOOD UREA INCREASED 8 0.0005
392 FOOT FRACTURE 9 0.0005
393 LIVER DISORDER 21 0.0005
394 BUNDLE BRANCH BLOCK LEFT 2 0.0005
395 SLEEP APNOEA SYNDROME 9 0.0005
396 INTRAOCULAR PRESSURE INCREASED 6 0.0005
397 CARDIAC FAILURE CHRONIC 2 0.0005
398 ENTERITIS 3 0.0005
399 INFLUENZA 52 0.0005
400 CARDIAC FLUTTER 3 0.0005
401 CARDIAC MURMUR 4 0.0005
402 DEVICE DEFECTIVE 8 0.0005
403 RESPIRATORY TRACT INFECTION 12 0.0005
404 SKIN LACERATION 5 0.0005
405 INTENTIONAL DOSE OMISSION 13 0.0005
406 DRUG INEFFECTIVE 600 0.0005
407 LOCALISED INFECTION 11 0.0005
408 TUMOUR LYSIS SYNDROME 4 0.0005
409 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
410 SARS-COV-2 TEST POSITIVE 6 0.0005
411 HERPES ZOSTER 26 0.0005
412 PRESCRIBED UNDERDOSE 9 0.0005
413 CARDIAC FAILURE ACUTE 3 0.0004
414 SKIN MASS 3 0.0004
415 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
416 BRAIN FOG 7 0.0004
417 INTESTINAL PERFORATION 5 0.0004
418 OXYGEN SATURATION DECREASED 25 0.0004
419 COLITIS ISCHAEMIC 3 0.0004
420 DEVELOPMENTAL DELAY 4 0.0004
421 TOOTHACHE 8 0.0004
422 SCIATICA 7 0.0004
423 NEPHROTIC SYNDROME 3 0.0004
424 NEOPLASM 5 0.0004
425 RESPIRATORY DISORDER 13 0.0004
426 BLOOD GLUCOSE ABNORMAL 8 0.0004
427 PLATELET COUNT DECREASED 46 0.0004
428 AUTOIMMUNE HEPATITIS 3 0.0004
429 BACK DISORDER 7 0.0004
430 APPENDICITIS 4 0.0004
431 DEFAECATION URGENCY 3 0.0004
432 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
433 ARTERIOSCLEROSIS 4 0.0004
434 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
435 RETINAL HAEMORRHAGE 3 0.0004
436 CHOLECYSTITIS 5 0.0004
437 GASTRITIS 11 0.0004
438 WRIST FRACTURE 5 0.0004
439 ANAPHYLACTIC REACTION 23 0.0004
440 DERMATITIS BULLOUS 3 0.0004
441 FAECES SOFT 3 0.0004
442 COUGH 114 0.0004
443 SPINAL OPERATION 5 0.0004
444 OEDEMA 22 0.0004
445 GENERALISED OEDEMA 5 0.0004
446 ILEUS 5 0.0004
447 ANEURYSM 2 0.0004
448 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
449 DERMATITIS ATOPIC 21 0.0004
450 PAROSMIA 3 0.0004
451 HYPOXIA 14 0.0004
452 HEPATOCELLULAR CARCINOMA 3 0.0004
453 FEEDING DISORDER 8 0.0004
454 STAPHYLOCOCCAL INFECTION 13 0.0004
455 ACIDOSIS 3 0.0004
456 THIRST 7 0.0004
457 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
458 LIPASE INCREASED 3 0.0004
459 CONDITION AGGRAVATED 119 0.0004
460 HYPOPHAGIA 10 0.0004
461 NEUTROPHIL COUNT INCREASED 4 0.0004
462 NASOPHARYNGITIS 72 0.0004
463 EUPHORIC MOOD 4 0.0004
464 EAR DISCOMFORT 4 0.0004
465 ROTATOR CUFF SYNDROME 5 0.0004
466 OROPHARYNGEAL PAIN 36 0.0004
467 FOOD ALLERGY 3 0.0004
468 ANKLE FRACTURE 6 0.0004
469 RASH GENERALISED 10 0.0004
470 HYPOALBUMINAEMIA 3 0.0004
471 GASTROINTESTINAL INFLAMMATION 3 0.0004
472 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
473 WEIGHT FLUCTUATION 4 0.0004
474 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
475 CYANOSIS 6 0.0004
476 HYPOTHYROIDISM 12 0.0004
477 ANAL FISSURE 2 0.0004
478 FRUSTRATION TOLERANCE DECREASED 3 0.0004
479 ANAL ABSCESS 2 0.0004
480 WHEEZING 22 0.0004
481 FIBROMYALGIA 9 0.0004
482 BLOOD BILIRUBIN INCREASED 10 0.0004
483 PRESYNCOPE 9 0.0004
484 TINNITUS 17 0.0004
485 BLOOD POTASSIUM INCREASED 6 0.0004
486 HYPOKALAEMIA 17 0.0004
487 GASTRIC ULCER 7 0.0004
488 HICCUPS 3 0.0004
489 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
490 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
491 EMBOLISM 3 0.0004
492 CARDIAC FAILURE 29 0.0004
493 ORAL DISCOMFORT 5 0.0004
494 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
495 HYPOMAGNESAEMIA 5 0.0004
496 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
497 URINARY TRACT INFECTION 61 0.0004
498 KIDNEY INFECTION 7 0.0004
499 SKIN INFECTION 4 0.0004
500 TYPE 2 DIABETES MELLITUS 12 0.0004
501 PNEUMONIA 115 0.0004
502 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
503 PRODUCT AVAILABILITY ISSUE 8 0.0004
504 PYREXIA 121 0.0003
505 EXPOSURE VIA SKIN CONTACT 9 0.0003
506 HYSTERECTOMY 3 0.0003
507 CYSTITIS 11 0.0003
508 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
509 ELECTROLYTE IMBALANCE 4 0.0003
510 NAIL DISORDER 3 0.0003
511 EOSINOPHILIA 6 0.0003
512 LYMPHOCYTE COUNT DECREASED 6 0.0003
513 LYMPHADENOPATHY 12 0.0003
514 VISUAL IMPAIRMENT 42 0.0003
515 BLOOD IRON DECREASED 4 0.0003
516 ATAXIA 4 0.0003
517 BACTERAEMIA 4 0.0003
518 PRODUCT DOSE OMISSION ISSUE 99 0.0003
519 DYSGEUSIA 25 0.0003
520 ACCIDENT 4 0.0003
521 HAEMOLYTIC ANAEMIA 3 0.0003
522 CHEST DISCOMFORT 34 0.0003
523 BLOOD COUNT ABNORMAL 5 0.0003
524 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
525 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
526 IRRITABLE BOWEL SYNDROME 7 0.0003
527 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
528 UROSEPSIS 3 0.0003
529 COVID-19 57 0.0003
530 MIGRAINE 31 0.0003
531 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
532 PRURITUS 124 0.0003
533 WOUND 9 0.0003
534 SEPTIC SHOCK 14 0.0003
535 HEPATIC ENCEPHALOPATHY 3 0.0003
536 DIARRHOEA HAEMORRHAGIC 3 0.0003
537 EPISTAXIS 24 0.0003
538 CARDIAC DISORDER 30 0.0003
539 INJECTION SITE DISCOLOURATION 4 0.0003
540 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
541 SKIN EXFOLIATION 27 0.0003
542 BLOOD SODIUM DECREASED 6 0.0003
543 DERMATITIS ALLERGIC 4 0.0003
544 HYPOCALCAEMIA 6 0.0003
545 DELIRIUM 11 0.0003
546 PROTEINURIA 6 0.0003
547 FEELING JITTERY 6 0.0003
548 RESPIRATORY TRACT CONGESTION 5 0.0003
549 DRY SKIN 42 0.0003
550 RASH MACULAR 11 0.0003
551 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
552 SEPSIS 35 0.0003
553 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
554 PRODUCT SUBSTITUTION ISSUE 18 0.0003
555 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
556 CHROMATURIA 7 0.0003
557 DECREASED APPETITE 72 0.0003
558 INJECTION SITE INDURATION 4 0.0003
559 HAEMORRHOIDS 6 0.0003
560 PHARYNGEAL SWELLING 3 0.0003
561 ERYTHEMA 63 0.0003
562 COELIAC DISEASE 3 0.0003
563 VITREOUS FLOATERS 3 0.0003
564 SHOCK 7 0.0003
565 WEIGHT INCREASED 68 0.0003
566 BLOOD PRESSURE ABNORMAL 6 0.0003
567 CYTOMEGALOVIRUS INFECTION 5 0.0003
568 URINARY RETENTION 10 0.0003
569 BLOOD POTASSIUM DECREASED 9 0.0003
570 HEPATIC FAILURE 9 0.0003
571 HEADACHE 187 0.0003
572 RASH 129 0.0003
573 ANAEMIA 56 0.0003
574 HEART RATE INCREASED 29 0.0003
575 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
576 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
577 INFLUENZA LIKE ILLNESS 24 0.0003
578 MUSCULOSKELETAL DISCOMFORT 5 0.0003
579 THROAT IRRITATION 13 0.0003
580 HYPERBILIRUBINAEMIA 3 0.0003
581 THERAPY NON-RESPONDER 13 0.0003
582 HAEMOPTYSIS 8 0.0003
583 NECK PAIN 16 0.0003
584 LUNG DISORDER 14 0.0003
585 CATARACT 17 0.0003
586 INJECTION SITE DISCOMFORT 3 0.0003
587 SCRATCH 3 0.0003
588 COLD SWEAT 5 0.0003
589 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
590 STOMATITIS 17 0.0003
591 GALLBLADDER DISORDER 5 0.0003
592 PARAESTHESIA ORAL 4 0.0003
593 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
594 DEVICE LEAKAGE 12 0.0003
595 PRODUCT DISPENSING ERROR 6 0.0003
596 OESOPHAGITIS 3 0.0003
597 JOINT SWELLING 33 0.0003
598 ASCITES 8 0.0003
599 RASH ERYTHEMATOUS 13 0.0003
600 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49 0.0003
601 ANAPHYLACTIC SHOCK 7 0.0003
602 BLINDNESS TRANSIENT 2 0.0003
603 OEDEMA PERIPHERAL 33 0.0003
604 FOOT DEFORMITY 3 0.0003
605 LIP SWELLING 9 0.0003
606 ARTHROPOD BITE 2 0.0003
607 RASH MACULO-PAPULAR 6 0.0003
608 URTICARIA 45 0.0003
609 DEAFNESS 7 0.0003
610 HEPATIC CIRRHOSIS 5 0.0003
611 INTESTINAL OBSTRUCTION 10 0.0003
612 MALAISE 116 0.0003
613 PLEURAL EFFUSION 16 0.0003
614 CHOLECYSTECTOMY 3 0.0003
615 BOWEL MOVEMENT IRREGULARITY 2 0.0003
616 INJECTION SITE SWELLING 20 0.0003
617 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
618 POST PROCEDURAL COMPLICATION 5 0.0003
619 FEAR 7 0.0003
620 JAUNDICE 7 0.0003
621 METASTASES TO LUNG 3 0.0003
622 PERICARDIAL EFFUSION 6 0.0003
623 CAESAREAN SECTION 3 0.0003
624 VASCULITIS 3 0.0003
625 DELUSION 4 0.0003
626 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
627 HYPERKALAEMIA 9 0.0003
628 THERAPY PARTIAL RESPONDER 4 0.0003
629 CHOKING 5 0.0003
630 SURGERY 15 0.0003
631 MYOCLONUS 3 0.0003
632 MACULAR DEGENERATION 3 0.0003
633 UPPER LIMB FRACTURE 5 0.0003
634 PANCYTOPENIA 14 0.0003
635 MYELOSUPPRESSION 9 0.0002
636 HEPATIC ENZYME INCREASED 17 0.0002
637 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
638 NOCTURIA 3 0.0002
639 SCHIZOPHRENIA 3 0.0002
640 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
641 CYTOPENIA 3 0.0002
642 ENCEPHALOPATHY 6 0.0002
643 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
644 SMALL INTESTINAL OBSTRUCTION 3 0.0002
645 OSTEOPOROSIS 10 0.0002
646 CYST 3 0.0002
647 SLEEP DISORDER 17 0.0002
648 DEHYDRATION 32 0.0002
649 RHABDOMYOLYSIS 10 0.0002
650 DYSPHONIA 14 0.0002
651 INJECTION SITE PRURITUS 16 0.0002
652 DERMATITIS 5 0.0002
653 BRAIN OEDEMA 3 0.0002
654 FACE OEDEMA 4 0.0002
655 HAEMATEMESIS 6 0.0002
656 PRODUCT QUALITY ISSUE 32 0.0002
657 CIRCULATORY COLLAPSE 4 0.0002
658 PRODUCT USE ISSUE 44 0.0002
659 MYDRIASIS 3 0.0002
660 ANURIA 2 0.0002
661 HIATUS HERNIA 3 0.0002
662 FAECES DISCOLOURED 5 0.0002
663 BLOOD CREATININE INCREASED 15 0.0002
664 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
665 DIZZINESS 114 0.0002
666 ANKYLOSING SPONDYLITIS 3 0.0002
667 PRODUCT USE IN UNAPPROVED INDICATION 56 0.0002
668 HEAD DISCOMFORT 4 0.0002
669 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
670 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
671 CEREBRAL HAEMORRHAGE 8 0.0002
672 SNEEZING 5 0.0002
673 PAIN OF SKIN 6 0.0002
674 PANCREATITIS ACUTE 5 0.0002
675 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 45 0.0002
676 HYPERTENSION 47 0.0002
677 THROAT TIGHTNESS 6 0.0002
678 PRODUCT TASTE ABNORMAL 3 0.0002
679 INSOMNIA 59 0.0002
680 ARTHRALGIA 92 0.0002
681 NO ADVERSE EVENT 40 0.0002
682 PERIPHERAL SWELLING 34 0.0002
683 PALLOR 6 0.0002
684 LEUKOPENIA 11 0.0002
685 GINGIVAL BLEEDING 3 0.0002
686 BACK PAIN 51 0.0002
687 RESTLESSNESS 8 0.0002
688 PERIPHERAL COLDNESS 3 0.0002
689 INJECTION SITE MASS 8 0.0002
690 ATRIAL FIBRILLATION 21 0.0002
691 APHONIA 3 0.0002
692 WEIGHT DECREASED 60 0.0002
693 HAEMOGLOBIN DECREASED 22 0.0002
694 BLISTER 12 0.0002
695 FEELING ABNORMAL 51 0.0002
696 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
697 BLOOD URINE PRESENT 4 0.0002
698 BRONCHOSPASM 3 0.0002
699 SUBDURAL HAEMATOMA 3 0.0002
700 DRY MOUTH 17 0.0002
701 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
702 GLAUCOMA 4 0.0002
703 DIARRHOEA 134 0.0002
704 PRESCRIBED OVERDOSE 4 0.0002
705 INJECTION SITE URTICARIA 5 0.0002
706 DYSPNOEA 115 0.0002
707 SWELLING 19 0.0002
708 BLOOD PRESSURE INCREASED 31 0.0002
709 TACHYCARDIA 18 0.0002
710 ABNORMAL BEHAVIOUR 8 0.0002
711 BLADDER DISORDER 2 0.0002
712 DEEP VEIN THROMBOSIS 13 0.0002
713 SWELLING FACE 13 0.0002
714 BURNING SENSATION 14 0.0002
715 BRAIN INJURY 2 0.0002
716 HOT FLUSH 15 0.0002
717 HYPOAESTHESIA ORAL 3 0.0002
718 THERAPEUTIC RESPONSE DECREASED 12 0.0002
719 EXTRA DOSE ADMINISTERED 8 0.0002
720 PRODUCT COMPLAINT 5 0.0002
721 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
722 DEVICE FAILURE 3 0.0002
723 SKIN IRRITATION 9 0.0002
724 RIB FRACTURE 4 0.0002
725 LYMPHOMA 3 0.0002
726 MUSCULOSKELETAL CHEST PAIN 3 0.0002
727 HYPOAESTHESIA 29 0.0002
728 MUSCULAR WEAKNESS 22 0.0002
729 LUNG INFECTION 3 0.0002
730 CRYING 7 0.0002
731 CONSTIPATION 42 0.0002
732 DIPLOPIA 5 0.0002
733 PANIC ATTACK 7 0.0002
734 POLLAKIURIA 8 0.0002
735 ABDOMINAL DISTENSION 20 0.0002
736 MOUTH ULCERATION 4 0.0002
737 DYSPHAGIA 18 0.0002
738 HEAD INJURY 6 0.0002
739 NAUSEA 150 0.0002
740 OSTEOARTHRITIS 8 0.0002
741 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
742 ULCER 3 0.0002
743 EATING DISORDER 4 0.0002
744 PALPITATIONS 22 0.0002
745 RETCHING 4 0.0002
746 CARDIAC FAILURE CONGESTIVE 15 0.0002
747 PAIN IN EXTREMITY 55 0.0002
748 FALL 62 0.0002
749 POOR QUALITY SLEEP 4 0.0002
750 LACTIC ACIDOSIS 6 0.0002
751 RASH PRURITIC 10 0.0002
752 HYPOTENSION 37 0.0002
753 METASTASES TO BONE 3 0.0002
754 PHOTOSENSITIVITY REACTION 3 0.0002
755 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
756 DISCOMFORT 11 0.0002
757 PROCEDURAL PAIN 5 0.0002
758 MUSCLE SPASMS 33 0.0002
759 GAIT INABILITY 6 0.0002
760 FEELING HOT 11 0.0002
761 DEMENTIA 5 0.0002
762 ABDOMINAL DISCOMFORT 30 0.0002
763 GASTROINTESTINAL DISORDER 16 0.0002
764 FLUSHING 18 0.0002
765 HEART RATE IRREGULAR 4 0.0002
766 FLUID RETENTION 9 0.0002
767 PAIN IN JAW 5 0.0002
768 RED BLOOD CELL COUNT DECREASED 5 0.0002
769 NEPHROLITHIASIS 8 0.0002
770 VOMITING 82 0.0002
771 INFLAMMATION 9 0.0002
772 PAIN 107 0.0002
773 MULTI-ORGAN FAILURE 3 0.0002
774 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
775 GAIT DISTURBANCE 33 0.0002
776 ORTHOSTATIC HYPOTENSION 3 0.0002
777 BLINDNESS 7 0.0002
778 MUSCULOSKELETAL PAIN 9 0.0002
779 RENAL DISORDER 8 0.0002
780 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
781 DEVICE USE ISSUE 3 0.0002
782 HEART RATE DECREASED 6 0.0002
783 THROMBOCYTOPENIA 19 0.0002
784 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
785 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
786 LABORATORY TEST ABNORMAL 5 0.0002
787 URINARY INCONTINENCE 5 0.0002
788 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
789 NEUROPATHY PERIPHERAL 16 0.0002
790 COMA 8 0.0002
791 PRODUCT PRESCRIBING ERROR 4 0.0002
792 CARDIO-RESPIRATORY ARREST 7 0.0002
793 RHEUMATOID ARTHRITIS 19 0.0002
794 FATIGUE 130 0.0002
795 SYNOVITIS 3 0.0002
796 IRRITABILITY 10 0.0002
797 GASTROENTERITIS VIRAL 3 0.0002
798 ARTHRITIS 13 0.0002
799 BURSITIS 2 0.0002
800 HYPERGLYCAEMIA 6 0.0002
801 UNDERDOSE 12 0.0002
802 EPILEPSY 5 0.0002
803 INJECTION SITE RASH 5 0.0002
804 INJECTION SITE BRUISING 13 0.0002
805 RECTAL HAEMORRHAGE 7 0.0002
806 CARDIOMEGALY 2 0.0002
807 CHEST PAIN 30 0.0002
808 ARTHROPATHY 9 0.0002
809 FEMUR FRACTURE 5 0.0002
810 INJECTION SITE ERYTHEMA 20 0.0002
811 HYPONATRAEMIA 9 0.0002
812 INJECTION SITE PAIN 49 0.0002
813 INFECTION 23 0.0002
814 FRACTURE 3 0.0002
815 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
816 GASTRIC CANCER 4 0.0002
817 DIABETES MELLITUS 12 0.0002
818 HEPATITIS 4 0.0002
819 ACUTE RESPIRATORY FAILURE 3 0.0002
820 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
821 ANOREXIA 2 0.0002
822 ANXIETY 44 0.0002
823 MOBILITY DECREASED 11 0.0002
824 DISABILITY 3 0.0002
825 HAEMATOCRIT DECREASED 3 0.0002
826 PREGNANCY 3 0.0001
827 PRODUCT PHYSICAL ISSUE 3 0.0001
828 ANGER 5 0.0001
829 NEUTROPENIA 20 0.0001
830 PNEUMONITIS 4 0.0001
831 TREATMENT NONCOMPLIANCE 8 0.0001
832 ABDOMINAL PAIN 34 0.0001
833 HAEMATURIA 5 0.0001
834 SKIN LESION 4 0.0001
835 CHILLS 17 0.0001
836 HAEMATOCHEZIA 8 0.0001
837 RESPIRATORY DISTRESS 4 0.0001
838 PERITONITIS 3 0.0001
839 PULMONARY HYPERTENSION 3 0.0001
840 NEOPLASM PROGRESSION 5 0.0001
841 CARPAL TUNNEL SYNDROME 2 0.0001
842 KNEE ARTHROPLASTY 3 0.0001
843 INJURY 10 0.0001
844 RENAL FAILURE ACUTE 6 0.0001
845 ABDOMINAL PAIN UPPER 29 0.0001
846 JOINT INJURY 3 0.0001
847 THERAPY INTERRUPTED 10 0.0001
848 AGGRESSION 7 0.0001
849 PARAESTHESIA 22 0.0001
850 HYPERHIDROSIS 18 0.0001
851 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
852 PRURITUS GENERALISED 3 0.0001
853 ASTHENIA 52 0.0001
854 INTENTIONAL PRODUCT MISUSE 12 0.0001
855 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
856 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
857 RENAL FAILURE 18 0.0001
858 CARDIOMYOPATHY 2 0.0001
859 MYALGIA 23 0.0001
860 CONTUSION 13 0.0001
861 TOOTH DISORDER 3 0.0001
862 PULMONARY OEDEMA 6 0.0001
863 ORAL PAIN 3 0.0001
864 RASH PAPULAR 3 0.0001
865 ADVERSE DRUG REACTION 12 0.0001
866 LOSS OF CONSCIOUSNESS 17 0.0001
867 PANCREATITIS 7 0.0001
868 DYSPEPSIA 13 0.0001
869 COLITIS 5 0.0001
870 DEPRESSION 30 0.0001
871 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
872 VERTIGO 8 0.0001
873 ACUTE KIDNEY INJURY 20 0.0001
874 SKIN DISCOLOURATION 6 0.0001
875 EMOTIONAL DISORDER 4 0.0001
876 BASAL CELL CARCINOMA 2 0.0001
877 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
878 TREMOR 21 0.0001
879 DISORIENTATION 5 0.0001
880 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
881 ABSCESS 2 0.0001
882 DIABETIC KETOACIDOSIS 3 0.0001
883 HIP FRACTURE 4 0.0001
884 HYPOGLYCAEMIA 6 0.0001
885 DEVICE BREAKAGE 5 0.0001
886 DYSKINESIA 5 0.0001
887 PRODUCT DOSE OMISSION 8 0.0001
888 AGITATION 9 0.0001
889 IMPAIRED HEALING 4 0.0001
890 LUNG NEOPLASM MALIGNANT 5 0.0001
891 SEIZURE 14 0.0001
892 OFF LABEL USE 106 0.0001
893 AGEUSIA 3 0.0001
894 SKIN DISORDER 4 0.0001
895 ABDOMINAL PAIN LOWER 3 0.0001
896 CARDIOVASCULAR DISORDER 3 0.0001
897 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
898 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
899 HYPOACUSIS 5 0.0001
900 SUICIDE ATTEMPT 7 0.0001
901 NERVOUSNESS 6 0.0001
902 HAEMORRHAGE 12 0.0001
903 JOINT STIFFNESS 3 0.0001
904 SOMNOLENCE 23 0.0001
905 MUSCULOSKELETAL STIFFNESS 10 0.0001
906 BREAST CANCER FEMALE 3 0.0001
907 DISTURBANCE IN ATTENTION 6 0.0001
908 OVERDOSE 24 0.0001
909 RESPIRATORY FAILURE 8 0.0001
910 DYSURIA 4 0.0001
911 ABNORMAL DREAMS 3 0.0001
912 FEELING COLD 3 0.0001
913 AGRANULOCYTOSIS 2 0.0001
914 DRUG INTERACTION 17 0.0001
915 DYSARTHRIA 4 0.0001
916 HALLUCINATION 8 0.0001
917 ARRHYTHMIA 5 0.0001
918 CHRONIC KIDNEY DISEASE 8 0.0001
919 INCORRECT DOSE ADMINISTERED 24 0.0001
920 ANGINA PECTORIS 3 0.0001
921 BLOOD GLUCOSE DECREASED 5 0.0001
922 BALANCE DISORDER 9 0.0001
923 DRUG INTOLERANCE 10 0.0001
924 NEEDLE ISSUE 3 0.0001
925 DYSSTASIA 3 0.0001
926 MEMORY IMPAIRMENT 14 0.0001
927 ALOPECIA 20 0.0001
928 APHASIA 3 0.0001
929 ILL-DEFINED DISORDER 6 0.0001
930 BONE MARROW FAILURE 2 0.0001
931 SUICIDAL IDEATION 9 0.0001
932 LIMB DISCOMFORT 3 0.0001
933 BREAST CANCER 9 0.0001
934 NERVOUS SYSTEM DISORDER 3 0.0001
935 SWOLLEN TONGUE 3 0.0001
936 BRADYCARDIA 5 0.0001
937 DISEASE PROGRESSION 11 0.0001
938 AMNESIA 6 0.0001
939 MENTAL DISORDER 4 0.0001
940 PSORIASIS 12 0.0001
941 MYOCARDIAL INFARCTION 16 0.0001
942 OSTEONECROSIS 3 0.0001
943 APPLICATION SITE PAIN 2 0.0001
944 ANGIOEDEMA 4 0.0001
945 VISUAL ACUITY REDUCED 3 0.0001
946 NEOPLASM MALIGNANT 6 0.0001
947 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
948 APPLICATION SITE PRURITUS 2 0.0001
949 INJECTION SITE REACTION 6 0.0001
950 LETHARGY 5 0.0001
951 COLORECTAL CANCER 4 0.0001
952 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
953 DRUG EFFECT INCOMPLETE 3 0.0001
954 ABASIA 2 0.0001
955 EXPOSURE DURING PREGNANCY 5 0.0001
956 SYNCOPE 8 0.0001
957 THERAPY CESSATION 4 0.0001
958 APPLICATION SITE ERYTHEMA 2 0.0001
959 INJECTION SITE HAEMORRHAGE 6 0.0001
960 THROMBOSIS 6 0.0001
961 EMOTIONAL DISTRESS 9 0.0001
962 PULMONARY EMBOLISM 7 0.0001
963 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
964 COMPLETED SUICIDE 6 0.0001
965 ROAD TRAFFIC ACCIDENT 3 0.0001
966 DEVICE MALFUNCTION 5 0.0001
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
968 PRODUCT STORAGE ERROR 6 0.0001
969 BONE PAIN 4 0.0001
970 ACUTE MYOCARDIAL INFARCTION 2 0.0001
971 COLITIS ULCERATIVE 3 0.0001
972 DEVICE ISSUE 6 0.0001
973 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
974 UNEVALUABLE EVENT 5 0.0001
975 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
976 BONE DENSITY DECREASED 2 0.0001
977 CEREBROVASCULAR ACCIDENT 10 0.0001
978 SPEECH DISORDER 3 0.0001
979 DRUG EFFECT DECREASED 3 0.0001
980 CONFUSIONAL STATE 9 0.0001
981 ADVERSE EVENT 5 0.0001
982 FLATULENCE 3 0.0001
983 ACNE 4 0.0001
984 CARDIAC ARREST 4 0.0000
985 DRUG DOSE OMISSION 8 0.0000
986 DRUG ABUSE 4 0.0000
987 BLOOD GLUCOSE INCREASED 9 0.0000
988 INTENTIONAL OVERDOSE 3 0.0000
989 DEATH 40 0.0000
990 SKIN BURNING SENSATION 3 0.0000
991 HOSPITALISATION 6 0.0000